| The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease P Barone, A Antonini, C Colosimo, R Marconi, L Morgante, TP Avarello, ... Movement disorders: official journal of the Movement Disorder Society 24 (11 …, 2009 | 1387 | 2009 |
| Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs FE Pontieri, G Tanda, F Orzi, G Di Chiara Nature 382 (6588), 255-257, 1996 | 1318 | 1996 |
| Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common µ1 opioid receptor mechanism G Tanda, FE Pontieri, G Di Chiara Science 276 (5321), 2048-2050, 1997 | 1272 | 1997 |
| Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the" shell" as compared with the" core" of the rat nucleus accumbens FE Pontieri, G Tanda, G Di Chiara Proceedings of the National Academy of Sciences 92 (26), 12304-12308, 1995 | 999 | 1995 |
| Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature P Péran, A Cherubini, F Assogna, F Piras, C Quattrocchi, A Peppe, ... Brain 133 (11), 3423-3433, 2010 | 384 | 2010 |
| Drug addiction as a disorder of associative learning: role of nucleus accumbens shell/extended amygdala dopamine G Di Chiara, G Tanda, V Bassareo, F Pontieri, E Acquas, S Fenu, ... Annals of the New York Academy of Sciences 877 (1), 461-485, 1999 | 302 | 1999 |
| The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life A Antonini, P Barone, R Marconi, L Morgante, S Zappulla, FE Pontieri, ... Journal of neurology 259 (12), 2621-2631, 2012 | 228 | 2012 |
| Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine G Tanda, FE Pontieri, R Frau, G Di Chiara European Journal of Neuroscience 9 (10), 2077-2085, 1997 | 194 | 1997 |
| Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, ... Neurology 74 (10), 839-845, 2010 | 163 | 2010 |
| Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study C Colosimo, L Morgante, A Antonini, P Barone, TP Avarello, E Bottacchi, ... Journal of neurology 257 (1), 5-14, 2010 | 147 | 2010 |
| The recognition of facial emotion expressions in Parkinson's disease F Assogna, FE Pontieri, C Caltagirone, G Spalletta European Neuropsychopharmacology 18 (11), 835-848, 2008 | 139 | 2008 |
| Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study GA Carlesimo, F Piras, F Assogna, FE Pontieri, C Caltagirone, G Spalletta Neurology 78 (24), 1939-1945, 2012 | 117 | 2012 |
| Neuropharmacology and behavior in planarians: translations to mammals FR Buttarelli, C Pellicano, FE Pontieri Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2008 | 108 | 2008 |
| The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders F R Buttarelli, A Fanciulli, C Pellicano, F E Pontieri Current neuropharmacology 9 (2), 278-288, 2011 | 95 | 2011 |
| Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression L Morgante, C Colosimo, A Antonini, R Marconi, G Meco, M Pederzoli, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (1), 76-82, 2012 | 93 | 2012 |
| Behavioral sensitization to heroin by cannabinoid pretreatment in the rat FE Pontieri, P Monnazzi, A Scontrini, FR Buttarelli, FR Patacchioli European journal of pharmacology 421 (3), R1-R3, 2001 | 89 | 2001 |
| Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease B Caronti, G Antonini, C Calderaro, S Ruggieri, G Palladini, FE Pontieri, ... Journal of neural transmission 108 (7), 803-807, 2001 | 83 | 2001 |
| Prodromal non-motor symptoms of Parkinson’s disease C Pellicano, D Benincasa, V Pisani, FR Buttarelli, M Giovannelli, ... Neuropsychiatric disease and treatment 3 (1), 145, 2007 | 80 | 2007 |
| Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease B Caronti, G Tanda, C Colosimo, S Ruggieri, C Calderaro, G Palladini, ... Neuroreport 10 (14), 2907-2910, 1999 | 79 | 1999 |
| Supine hypertension in Parkinson’s disease and multiple system atrophy A Fanciulli, G Göbel, JP Ndayisaba, R Granata, S Duerr, S Strano, ... Clinical Autonomic Research 26 (2), 97-105, 2016 | 75 | 2016 |
